Long Cast Advisers, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, the Portfolio’s cumulative net return increased by 1%, but the cumulative portfolio for the year remained flat. Since its inception in November 2015, the portfolio has delivered a cumulative return of 271% net of fees, outperforming major indices such as the Russell 2000 Index, the iShares US MicroCap ETF, and the iShares SmallCap EAFE (ex-N. Am) ETF for small-cap equities. By year-end, the 28 SMA accounts managed by Long Cast had an AUM of $12M. The firm, with its long-term focus on small companies, has seen returns that varied relative to the broader market, as reflected in its 10-year performance history. Please review the Portfolio’s top five holdings to gain insights into their key selections for 2025.
In its fourth-quarter 2025 investor letter, Long Cast Advisers highlighted stocks like Cross Country Healthcare, Inc. (NASDAQ:CCRN). Cross Country Healthcare, Inc. (NASDAQ:CCRN) is an American company that provides talent management services for healthcare clients specialize in nurse and allied staffing, and physician staffing. On March 11, 2026, Cross Country Healthcare, Inc. (NASDAQ:CCRN) stock closed at $9.78 per share. One-month return of Cross Country Healthcare, Inc. (NASDAQ:CCRN) was 23.02%, and its shares lost 37.94% over the past 52 weeks. Cross Country Healthcare, Inc. (NASDAQ:CCRN) has a market capitalization of $318.34 million.
Long Cast Advisers stated the following regarding Cross Country Healthcare, Inc. (NASDAQ:CCRN) in its fourth quarter 2025 investor letter:
“Our largest purchases in the quarter were PDEX, Cross Country Healthcare, Inc. (NASDAQ:CCRN) and NRC. CCRN ($8.24 avg price). We are revisiting the nurse staffing company we first owned back in 2019 and sold when COVID comps turned negative. At $8 / share and with 32M shares out, the company has a $260M market capitalization. At its most recent quarter, the company had $99M in net cash and no debt. In December it received a $20M termination payment following its failed $615M acquisition by AYA. This leaves it with over 40% of its market cap in cash and a pro forma enterprise value of $140M.
Of the large nurse staffing companies, CCRN is one of the smallest and has long lagged its peer group in profitability. We originally owned this because founder Kevin Clark had returned after a +20-year absence, and the stock was cheap. We had anticipated that his management and entrepreneurial experience would alter the culture and cadence of the business, and help it achieve margins closer to industry averages…” (Click here to read the full text)
Cross Country Healthcare, Inc. (NASDAQ:CCRN) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 28 hedge fund portfolios held Cross Country Healthcare, Inc. (NASDAQ:CCRN) at the end of the fourth quarter, compared to 33 in the previous quarter. In Q4 2025, Cross Country Healthcare, Inc. (NASDAQ:CCRN) generated revenue of $237 million, down 5% sequentially and 24% over the prior year. While we acknowledge the risk and potential of Cross Country Healthcare, Inc. (NASDAQ:CCRN) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Cross Country Healthcare, Inc. (NASDAQ:CCRN) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In addition, please check out our hedge fund investor letters Q4 2025 page for more investor letters from hedge funds and other leading investors.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. This article is originally published at Insider Monkey.
